These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2834998

  • 1. Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogs.
    Appelbaum FR, Meyers JD, Deeg HJ, Graham T, Schuening F, Storb R.
    Antimicrob Agents Chemother; 1988 Feb; 32(2):271-3. PubMed ID: 2834998
    [Abstract] [Full Text] [Related]

  • 2. Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine.
    Selby P, Powles RL, Jameson B, Stolle K, Tryhorn Y, Stern H.
    Lancet; 1986 Jun 14; 1(8494):1377-8. PubMed ID: 2872484
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids.
    Reed EC, Dandliker PS, Meyers JD.
    Ann Intern Med; 1986 Aug 14; 105(2):214-5. PubMed ID: 3014941
    [No Abstract] [Full Text] [Related]

  • 4. Effect of 9-(2-hydroxy-1-[hydroxymethyl] ethoxymethyl) guanine (DHPG) on cytomegalovirus pneumonitis after renal transplantation.
    Stoffel M, Gianello P, Squifflet JP, Pirson Y, Alexandre GP.
    Transplantation; 1988 Oct 14; 46(4):594-5. PubMed ID: 2845613
    [No Abstract] [Full Text] [Related]

  • 5. Active cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir).
    Teich SA, Castle J, Friedman AH, Siroty W, Orellana J, Schmitterer M.
    Br J Ophthalmol; 1988 Apr 14; 72(4):293-8. PubMed ID: 2837272
    [Abstract] [Full Text] [Related]

  • 6. Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).
    Orellana J, Teich SA, Winterkorn JS, Mathur-Wagh U, Handwerger S, Schlamm H, Malamud SC, Yancovitz SR, Cederberg DM, Mildvan DS.
    Br J Ophthalmol; 1988 Jul 14; 72(7):525-9. PubMed ID: 2843219
    [Abstract] [Full Text] [Related]

  • 7. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.
    Shepp DH, Dandliker PS, de Miranda P, Burnette TC, Cederberg DM, Kirk LE, Meyers JD.
    Ann Intern Med; 1985 Sep 14; 103(3):368-73. PubMed ID: 2992333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent.
    Pulido J, Peyman GA, Lesar T, Vernot J.
    Arch Ophthalmol; 1985 Jun 14; 103(6):840-1. PubMed ID: 3873931
    [Abstract] [Full Text] [Related]

  • 11. Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine.
    Rosecan LR, Stahl-Bayliss CM, Kalman CM, Laskin OL.
    Am J Ophthalmol; 1986 Apr 15; 101(4):405-18. PubMed ID: 3008560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
    Winston DJ, Yeager AM, Chandrasekar PH, Snydman DR, Petersen FB, Territo MC, Valacyclovir Cytomegalovirus Study Group.
    Clin Infect Dis; 2003 Mar 15; 36(6):749-58. PubMed ID: 12627359
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ, Busuttil RW.
    Transplantation; 2003 Jan 27; 75(2):229-33. PubMed ID: 12548129
    [Abstract] [Full Text] [Related]

  • 18. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
    Winston DJ, Ho WG, Bartoni K, Holland GN, Mitsuyasu RT, Gale RP, Busuttil RW, Champlin RE.
    Rev Infect Dis; 1988 Jan 27; 10 Suppl 3():S547-53. PubMed ID: 2847292
    [Abstract] [Full Text] [Related]

  • 19. Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia.
    Boeckh M, Gooley TA, Bowden RA.
    J Infect Dis; 1998 Oct 27; 178(4):1153-7. PubMed ID: 9806049
    [Abstract] [Full Text] [Related]

  • 20. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
    Aulitzky WE, Tilg H, Niederwieser D, Hackl M, Meister B, Huber C.
    J Infect Dis; 1988 Aug 27; 158(2):488-9. PubMed ID: 2841384
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.